CN104721801A - Medication for treating bronchial asthma - Google Patents

Medication for treating bronchial asthma Download PDF

Info

Publication number
CN104721801A
CN104721801A CN201510175209.6A CN201510175209A CN104721801A CN 104721801 A CN104721801 A CN 104721801A CN 201510175209 A CN201510175209 A CN 201510175209A CN 104721801 A CN104721801 A CN 104721801A
Authority
CN
China
Prior art keywords
bronchial asthma
fruit
medication
medicine
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510175209.6A
Other languages
Chinese (zh)
Inventor
刘国良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510175209.6A priority Critical patent/CN104721801A/en
Publication of CN104721801A publication Critical patent/CN104721801A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a medication for treating bronchial asthma, comprising 40g of ginseng, 30g of prepared rhizome of rehmannia, 20g of pulp of dogwood fruit, 16g of medicinal cyathula root, 6g of fruit of Chinese magnoliavine, 6g of malaytea scurfpea fruit, 6g of wolfberry fruit, 30g of dwarf lilyturf tuber, three peeled walnuts and five pieces of ginger. The medication made from herbs is convenient to use, has a short course of treatment, takes effect fast and has high therapeutic effect; therapeutic structural observation on 60% of patients show that total efficiency is above 97%.

Description

A kind of medicine for the treatment of bronchial asthma
Technical field
The present invention relates to treating asthma field, particularly relate to a kind of medicine for the treatment of bronchial asthma.
Background technology
Bronchial asthma participates in chronic airway inflammation illness by various kinds of cell (as eosinophilic granulocyte, mastocyte, T lymphocyte, neutrophilic granulocyte, human airway epithelial cells etc.) and cellular component.This chronic inflammatory disease causes the generation of airway hyperreactivity, the reversible airflow limitation that usual appearance is extensively changeable, and causing the symptoms such as the panting of recurrent exerbation, out of breath, uncomfortable in chest or cough, be everlasting night and (or) outbreak in morning, most of patients can spontaneous remissions or alleviate through treatment.
Can be divided into according to its mechanism of action and have expansion bronchus effect and the large class of antiinflammatory action two, some drugs has expansion bronchus and antiinflammatory action concurrently.(1) expansion bronchus medicine beta 2 receptor agonist, theophylline class.(2) anti-inflammatory drug glucocorticoid, leukotrienes regulator, sodium cromoglicate and Buddhist nun's polyacid sodium, anti-1gE monoclonal antibody, antihistamine drug.
But this medicine is hormone medicine, side reaction is comparatively large, and life-time service health can produce dependency to medicine, causes other to damage.
In view of the foregoing, creator of the present invention obtains this medicine finally through long research and practice.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of bronchial asthma in order to overcome above-mentioned technological deficiency.
For achieving the above object, the invention provides a kind of medicine for the treatment of bronchial asthma, its composition consists of: Radix Ginseng 40g, Radix Rehmanniae Preparata 30g, Fructus Corni 20g, Radix Cyathulae 16g, Fructus Schisandrae Chinensis 6g, Fructus Psoraleae 6g, Fructus Lycii 6g, Radix Ophiopogonis 30g, Semen Juglandis 3 peeling, 5, Rhizoma Zingiberis Recens.
Beneficial effect of the present invention is compared with prior art: the present invention is that raw material makes with Chinese herbal medicine, easy to use, short treating period, instant effect, and curative effect is high, and by the patient treatment constructed observation to 60%, total effective rate is more than 97%.
Detailed description of the invention
Below, to above-mentioned being described in more detail with other technical characteristic and advantage of the present invention.
The medicine for the treatment of bronchial asthma of the present invention, its composition consists of: Radix Ginseng 40g, Radix Rehmanniae Preparata 30g, Fructus Corni 20g, Radix Cyathulae 16g, Fructus Schisandrae Chinensis 6g, Fructus Psoraleae 6g, Fructus Lycii 6g, Radix Ophiopogonis 30g, Semen Juglandis 3 peeling, 5, Rhizoma Zingiberis Recens.
The mechanism of said medicine is: Radix Ginseng is " monarch ", is strong beta stimulant, and to general weakness person, neurastheniac, anemia, dyspepsia, mends greatly.
Radix Cyathulae is " minister ", liver and kidney tonifying, bone and muscle strengthening, impotence in male, and woman loses excessive, evacuation of pus, dispelling malignant blood, and only urine, controls blood pains in the penis.
Radix Rehmanniae Preparata Russia day " minister ", being usually used in the people of weakness, having the effect of heart tonifying of enriching blood, is also hemorrhage, the hectic fever of pulmonary tuberculosis with it, nourishing kidney marrow and benefitting semen.
Radix Ophiopogonis is " minister ", strong for nourishing, heart tonifying relieving cough and expelling phlegm, the merit of diuresis of quenching the thirst.
Fructus Corni is " minister ", and treatment pulmonary tuberculosis, hectic fever, dizzy, tinnitus, the kidney invigorating gas, Xing Yangdao, adds marrow, settling five organs.
Fructus Lycii is " minister ", treatment tuberculosis, the kidney invigorating principal agent.
Fructus Schisandrae Chinensis is " assistant ", and cough medicine, controls impairment caused by overstrain, tonify deficiency, and improving eyesight is brought down a fever, and controls and rushes down, and determines cough with asthma.
Fructus Psoraleae is " assistant ", strong body constitution, tonifying YANG, and QI invigorating is pleasant.
Semen Juglandis is " making ", nourishes medea, antitussive, tonifying five ZANG-organs.
Rhizoma Zingiberis Recens is " making ", dispels cold, stomach warming.
Model case:
Case one: Zhang, man, 74 years old, bronchial asthma was serious, and regardless of the spring, summer, autumn and winter, the four seasons can not leave the bed, and reuse medicine without improvement; Nineteen ninety took said medicine after 3 months, and the state of an illness thoroughly takes a turn for the better, to 2010 years euthesias.
Case two: Chen, man, 76 years old, ill decades, medication was countless, and hospital all went, and failed to fully recover, and within 2010, take the treatment of this prescription after two months, sb.'s illness took a favorable turn, now euthesia.
Case three, Chen, female, 64 years old, bronchial asthma decades, does not feel any better through each hospitalize; Within 2006, take this prescription, after 4 months, sb.'s illness took a favorable turn, so far euthesia.
The foregoing is only preferred embodiment of the present invention, is only illustrative for invention, and nonrestrictive.Those skilled in the art is understood, and can carry out many changes in the spirit and scope that invention claim limits to it, amendment, even equivalence, but all will fall within the scope of protection of the present invention.

Claims (1)

1. treat a medicine for bronchial asthma, it is characterized in that, its composition consists of: Radix Ginseng 40g, Radix Rehmanniae Preparata 30g, Fructus Corni 20g, Radix Cyathulae 16g, Fructus Schisandrae Chinensis 6g, Fructus Psoraleae 6g, Fructus Lycii 6g, Radix Ophiopogonis 30g, Semen Juglandis 3 peeling, 5, Rhizoma Zingiberis Recens.
CN201510175209.6A 2015-04-15 2015-04-15 Medication for treating bronchial asthma Pending CN104721801A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510175209.6A CN104721801A (en) 2015-04-15 2015-04-15 Medication for treating bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510175209.6A CN104721801A (en) 2015-04-15 2015-04-15 Medication for treating bronchial asthma

Publications (1)

Publication Number Publication Date
CN104721801A true CN104721801A (en) 2015-06-24

Family

ID=53446597

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510175209.6A Pending CN104721801A (en) 2015-04-15 2015-04-15 Medication for treating bronchial asthma

Country Status (1)

Country Link
CN (1) CN104721801A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108815368A (en) * 2018-08-27 2018-11-16 珠海横琴新区德群中医药科学研究院有限公司 It is a kind of for treating the Chinese medicine of asthma

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1879797A (en) * 2006-04-29 2006-12-20 金方义 A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same
CN100998737A (en) * 2006-12-26 2007-07-18 章丽美 Oral traditional Chinese medicine for treating cough type asthma
CN101444593A (en) * 2008-11-24 2009-06-03 律北平 Chinese traditional medical formula taken orally for curing asthma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1879797A (en) * 2006-04-29 2006-12-20 金方义 A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same
CN100998737A (en) * 2006-12-26 2007-07-18 章丽美 Oral traditional Chinese medicine for treating cough type asthma
CN101444593A (en) * 2008-11-24 2009-06-03 律北平 Chinese traditional medical formula taken orally for curing asthma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108815368A (en) * 2018-08-27 2018-11-16 珠海横琴新区德群中医药科学研究院有限公司 It is a kind of for treating the Chinese medicine of asthma

Similar Documents

Publication Publication Date Title
CN103550517B (en) A kind of medicine of Hepatoma therapy
CN103520607B (en) Traditional Chinese medicine preparation used for treating gastritis
CN102430097A (en) Chinese medicine for treating vitiligo
CN104435764A (en) Traditional Chinese medicine composition for treating diabetes and preparation process thereof
CN104721801A (en) Medication for treating bronchial asthma
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN103860707A (en) Pure traditional Chinese medicine preparation used for treating pruritus vulvae
CN103272159A (en) Chinese herbal preparation used for treating consumptive disease and preparation method thereof
CN102940723A (en) Traditional Chinese medicine composition for treating Qi deficiency type menstrual extension
CN102805848A (en) Chinese medicinal composition for treating dysmenorrhea
CN103191303B (en) Traditional Chinese medicine for treating night sweat
CN105617322A (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN103330760A (en) Medicament used for treating allergic purpura
CN104707009B (en) A kind of Chinese medicine for the treatment of type of blood-stasis obstructing in the interior anaphylactoid purpura
CN104587034B (en) New application of a medicinal composition in treating oral ulcer
CN103157006A (en) Oral traditional Chinese medicine formula for treating osteoarthritis
CN102406913A (en) Chinese medicinal composition for treating melancholia
CN102441110A (en) Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism
CN102389538B (en) Traditional Chinese medicine capsule preparation for treating nasopharyngitis
CN101623441B (en) Traditional Chinese medicine for treating chronic sphagitis
CN105535545A (en) Traditional Chinese medicine preparation for treating thrombopenia caused by benzene poisoning
CN105412244A (en) Traditional Chinese medicine composition treating gynecological cervicitis
CN105055814A (en) Traditional Chinese medicine composition for treating gout
CN105106590A (en) Medicine for treating allergic rhinitis
CN104840757A (en) Traditional Chinese medicine preparation for alleviating dysmenorrheal and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150624